< a href="http://feeds.parentprojectmd.org/~ff/ppmd?a=cVggQuCodlg:IT42g2BtYxg:yIl2AUoC8zA" > < img src="http://feeds.feedburner.com/~ff/ppmd?d=yIl2AUoC8zA" border="0" > < /img > < /..."> < a href="http://feeds.parentprojectmd.org/~ff/ppmd?a=cVggQuCodlg:IT42g2BtYxg:yIl2AUoC8zA" > < img src="http://feeds.feedburner.com/~ff/ppmd?d=yIl2AUoC8zA" border="0" > < /img > < /..." /> < a href="http://feeds.parentprojectmd.org/~ff/ppmd?a=cVggQuCodlg:IT42g2BtYxg:yIl2AUoC8zA" > < img src="http://feeds.feedburner.com/~ff/ppmd?d=yIl2AUoC8zA" border="0" > < /img > < /..." />

BMS & The Voice of the Patient

It is a good day when a global biopharmaceutical company commits to focusing on Duchenne. We are grateful that Bristol-Myers Squibb (BMS) has added another possibility for our toolbox of hope! < div class="feedflare" > < a href="http://feeds.parentprojectmd.org/~ff/ppmd?a=cVggQuCodlg:IT42g2BtYxg:yIl2AUoC8zA" > < img src="http://feeds.feedburner.com/~ff/ppmd?d=yIl2AUoC8zA" border="0" > < /img > < /a > < a href="http://feeds.parentprojectmd.org/~ff/ppmd?a=cVggQuCodlg:IT42g2BtYxg:qj6IDK7rITs" > < img src="http://feeds.feedburner.com/~ff/ppmd?d=qj6IDK7rITs" border="0" > < /img > < /a > < a href="http://feeds.parentprojectmd.org/~ff/ppmd?a=cVggQuCodlg:IT42g2BtYxg:V_sGLiPBpWU" > < img src="http://feeds.feedburner.com/~ff/ppmd?i=cVggQuCodlg:IT42g2BtYxg:V_sGLiPBpWU" border="0" > < /img > < /a > < a href="http://feeds.parentprojectmd.org/~ff/ppmd?a=cVggQuCodlg:IT42g2BtYxg:F7zBnMyn0Lo" > < img src="http://feeds.feedburner.com/~ff/ppmd?i=cVggQuCodlg:IT42g2BtYxg:F7zBnMyn0Lo" border="0" > < /img > < /a > < a href="http://feeds.parentprojectmd.org/~ff/ppmd?a=cVggQuCodlg:IT42g2BtYxg:gIN9vFwOqvQ" > < img src="http://feeds.feedburner.com/~ff/ppmd?i=cVggQuCodlg:IT42g2BtYxg:gIN9vFwOqvQ" border="0" > < /img > < /a > < /div > < img src="http://feeds.feedburner.com/~r/ppmd/~4/cVggQuCodlg" height="1" width="1" alt=""/ >
Source: Parent Project Muscular Dystrophy - Category: Neurology Source Type: news